Article
A Review of the Utility and Cost Effectiveness of Monitoring Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management.
Managed care (Langhorne, Pa.) - 1 Jul 2018
Arnold Renée Jg, Massanari Marc, Lee Todd A, Brooks Elizabeth
Abstract excerpt
Asthma is a common chronic respiratory disease affecting nearly 8% of the U.S. POPULATION: It results in substantially higher direct and indirect costs as well as an increased mortality risk and poorer quality of life, particularly among patients with difficult-to-control asthma. While several physiologic tests, including spirometry, are typically used to diagnose and characterize asthma, they do not provide the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.